SCHEMBL22456496

SCHEMBL22456496

CP(C)(=O)c1ccc(-c2ccc(-c3ccc4c5ccccc5c5nc6ccccc6n5c4c3)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.46
KDM4E B2RXH2 7/20 0.46
HPGD P15428 7/20 0.46
KMT2A Q03164 6/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
MAPT P10636 5/20 0.44
POLB P06746 5/20 0.44
HSD17B10 Q99714 3/20 0.44
LMNA P02545 2/20 0.44
TP53 P04637 1/20 0.44
MEN1 O00255 4/20 0.41
BCL2 P10415 1/20 0.38
CAMKK1 Q8N5S9 2/20 0.38
CAMKK2 Q96RR4 2/20 0.38
CSNK2A2 P19784 1/20 0.38
CSNK2B P67870 1/20 0.38
CSNK2A1 P68400 1/20 0.38
PIM3 Q86V86 1/20 0.38
DYRK2 Q92630 1/20 0.38
MKNK1 Q9BUB5 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22456456 1.00 ALDH1A1 (0.46) ALDH1A1KDM4EHPGDKMT2ASMN1; SMN2
SCHEMBL22456944 0.93 KDM4E (0.44) ALDH1A1KDM4EHPGDKMT2ASMN1; SMN2
SCHEMBL22456798 0.92 ALDH1A1 (0.43) ALDH1A1KDM4EHPGDKMT2ASMN1; SMN2
SCHEMBL22457010 0.92 ALDH1A1 (0.43) ALDH1A1KDM4EHPGDKMT2ASMN1; SMN2
SCHEMBL22456454 0.91 ALDH1A1 (0.41) ALDH1A1KDM4EHPGDKMT2ASMN1; SMN2
SCHEMBL22456532 0.91 KDM4E (0.49) ALDH1A1KDM4EHPGDKMT2ASMN1; SMN2
SCHEMBL22456447 0.91 ALDH1A1 (0.42) ALDH1A1KDM4EHPGDKMT2ASMN1; SMN2
SCHEMBL22456809 0.89 ALDH1A1 (0.42) ALDH1A1KDM4EHPGDKMT2ASMN1; SMN2
SCHEMBL15479214 0.89 HPGD (0.50) ALDH1A1KDM4EHPGDKMT2ASMN1; SMN2
SCHEMBL15479209 0.89 HPGD (0.50) ALDH1A1KDM4EHPGDKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200303661-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2020-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200303661-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME NR2E3, NR2E1, NOX1 ALDH1A1 2038/4885KDM4E 2372/4885HPGD 4184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.